CLINICAL TRIALS

Breast Cancer Clinical Trials Colorectal Cancer Lung Cancer Phase II

Next-Generation Sequencing-Guided Therapy for Advanced Cancers

Advanced Prostate Cancer Clinical Trials Metastatic Castration-Resistant Prostate Cancer Phase II Prostate Cancer

Advanced Prostate Cancer Immunotherapy Trial

Clinical Trials Colorectal Cancer Phase III Stage III Colorectal Cancer

Maintenance Immunotherapy for High-Risk Colorectal Cancer

Breast Cancer Clinical Trials Colorectal Cancer Lung Cancer Pancreatic Cancer Phase I Phase II

Oncolytic Virus Plus CAR-T Cell Therapy

Adrenal Cancer Bile Duct Cancer Clinical Trials Neuroendocrine Tumors Phase II Rare Solid Tumors Sarcomas Thymic Tumors

Precision Medicine for Rare Cancers

Breast Cancer Clinical Trials Colorectal Cancer Lung Cancer Phase I Prostate Cancer

Focal Ablation Plus Immunotherapy for Oligometastatic Disease

Breast Cancer Clinical Trials Metastatic Breast Cancer Phase II Triple-Negative Breast Cancer

Immunotherapy Combinations for Triple-Negative Breast Cancer

Advanced Melanoma Clinical Trials Cutaneous Melanoma Metastatic Melanoma Phase I

CRISPR-Enhanced TILs for Melanoma

Advanced NSCLC with Targetable Mutations Clinical Trials Lung Cancer Non-Small Cell Lung Cancer Phase II

Liquid Biopsy-Guided Lung Cancer Treatment

Breast Cancer Clinical Trials Colorectal Cancer Lung Cancer Phase I Phase II Prostate Cancer

Multi-Target CAR-T Cells for Solid Tumors

Clinical Trials Metastatic Pancreatic Adenocarcinoma Pancreatic Cancer Phase III

Nanotechnology Chemotherapy for Pancreatic Cancer

Brain Metastases Brain Tumour Clinical Trials Glioblastoma Phase I Recurrent Brain Cancer

Quantum-Enhanced Drug Combinations for Brain Tumors

Clinical Trials Diffuse Large B-Cell Lymphoma Follicular Lymphoma Leukemia/Lymphoma Mantle Cell Lymphoma Phase II

AI-Guided CAR-T Cell Therapy Trial

Breast Cancer Clinical Trials Colorectal Cancer Lung Cancer Pancreatic Cancer Phase I Phase II

Personalized Neoantigen Vaccines Trial